In conclusion, this study showed that the DLPFC can be
used as a brain structural marker to detect subjects with
schizophrenia using an integrated innovative ROI-SVM
approach. Similar investigations should be carried out in
first-episode patients, considering males and females separately
since they may express differential patterns of
DLPFC neuropathology.